Cladribine therapy for systemic mastocytosisKLUIN-NELEMANS, Hanneke C; OLDHOFF, J. Marja; VAN DOORMAAL, Jasper J et al.Blood. 2003, Vol 102, Num 13, pp 4270-4276, issn 0006-4971, 7 p.Article

Efficient syntheses of 2-chloro-2'-deoxyadenosine (cladribine) from 2'-deoxyguanosineJANEBA, Zlatko; FRANCOM, Paula; ROBINS, Morris J et al.Journal of organic chemistry. 2003, Vol 68, Num 3, pp 989-992, issn 0022-3263, 4 p.Article

Development of oral cladribine for the treatment of multiple sclerosisHARTUNG, Hans-Peter; AKTAS, Orhan; KIESEIER, Bernd et al.Journal of neurology. 2010, Vol 257, Num 2, pp 163-170, issn 0340-5354, 8 p.Article

Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman Disease) treated with 2-chlorodeoxyadenosineTASSO, M; ESQUEMBRE, C; BLANCO, E et al.Pediatric blood & cancer. 2006, Vol 47, Num 5, pp 612-615, issn 1545-5009, 4 p.Article

Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemiaLINDEMALM, Synnöve; LILIEMARK, Jan; GRUBER, Astrid et al.Haematologica (Roma). 2003, Vol 88, Num 3, pp 324-332, issn 0390-6078, 9 p.Article

Successful treatment of cutaneous langerhans cell histiocytosis with thalidomideSANDER, C. S; KAATZ, M; ELSNER, P et al.Dermatology (Basel). 2004, Vol 208, Num 2, pp 149-152, issn 1018-8665, 4 p.Article

Seventy-nine-year-old man with Langerhans cell histiocytosis treated with cladribineBLACK, Allyson; BERSHOW, Andrea; ALLEN, Pamela S et al.Journal of the American Academy of Dermatology. 2011, Vol 65, Num 3, pp 681-683, issn 0190-9622, 3 p.Article

Perspectives on purine analoguesCHESON, B. D.Hematology and cell therapy (Print). 1996, Vol 38, pp S109-S116, issn 1269-3286, SUP2Article

The clinical pharmacokinetics of cladribineLILIEMARK, J.Clinical pharmacokinetics. 1997, Vol 32, Num 2, pp 120-131, issn 0312-5963Article

t(11;18)-Bearing pulmonary mucosa-associated lymphoid tissue lymphoma responding to cladribineKUSUMOTO, Shigeru; KOBAYASHI, Yukio; TOBINAI, Kensei et al.International journal of hematology. 2004, Vol 80, Num 1, pp 70-74, issn 0925-5710, 5 p.Article

Influence of p53 and p21^WAF1 expression on sensitivity of cancer cells to cladribineGALMARINI, Carlos Maria; VOORZANGER, Nathalie; FALETTE, Nicole et al.Biochemical pharmacology. 2003, Vol 65, Num 1, pp 121-129, issn 0006-2952, 9 p.Article

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) studyCOOK, S; VERMERSCH, P; VIGLIETTA, V et al.Multiple sclerosis. 2011, Vol 17, Num 5, pp 578-593, issn 1352-4585, 16 p.Article

Oligoarthrite à histiocytes spumeux associée à une histiocytose systémique langerhansienne: observation et revue de la littératureAOUBA, Achille; LAROUSSERIE, Frédérique; LE GUERN, Véronique et al.Revue du rhumatisme (Ed. française). 2009, Vol 76, Num 12, pp 1351-1355, issn 1169-8330, 5 p.Article

Mastocytoses: avancées dans le diagnostic moléculaire et la thérapeutique = Mastocytosis: advances in molecular diagnosis and therapeuticsAROCK, M.Annales pharmaceutiques françaises. 2004, Vol 62, Num 4, pp 233-243, issn 0003-4509, 11 p.Article

Phase II clinical study of cladribine in the treatment of hairy cell leukemiaMACHII, Takashi; CHOU, Takaaki; OHASHI, Yasuo et al.International journal of hematology. 2005, Vol 82, Num 3, pp 230-235, issn 0925-5710, 6 p.Article

Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cellsHAN, Tieran; FERNANDEZ, Marilyn; CHOU, Ting-Chao et al.Journal of cancer research and clinical oncology. 2005, Vol 131, Num 9, pp 609-616, issn 0171-5216, 8 p.Article

A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseasesODENIKE, Olatoyosi M; SOBECKS, Ronald M; JANISCH, Linda et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 6, pp 553-561, issn 0344-5704, 9 p.Article

Cladribine as a therapeutic option in multiple sclerosisWARNKE, Clemens; LEUSSINK, Verena I; GOEBELS, Norbert et al.Clinical immunology (Orlando, Fla. Print). 2012, Vol 142, Num 1, pp 68-75, issn 1521-6616, 8 p.Article

Managing MS in a changing treatment landscapeDUDDY, Martin; HAGHIKIA, Aiden; COCCO, Eleonora et al.Journal of neurology. 2011, Vol 258, Num 5, pp 728-739, issn 0340-5354, 12 p.Article

Smouldering systemic mastocytosis: Erfolgreiche Therapie mit Cladribin = Smoldering systemic mastocytosiss. Successful therapy with cladribineSCHLEYER, V; MEYER, S; LANDTHALER, M et al.Hautarzt. 2004, Vol 55, Num 7, pp 658-662, issn 0017-8470, 5 p.Article

The effects of cladribine and fludarabine on DNA methylation in K562 cellsWYCZECHOWSKA, Dorota; FABIANOWSKA-MAJEWSKA, Krystyna.Biochemical pharmacology. 2003, Vol 65, Num 2, pp 219-225, issn 0006-2952, 7 p.Article

Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trialRUBNITZ, J. E; CREWS, K. R; RIBEIRO, R. C et al.Leukemia. 2009, Vol 23, Num 8, pp 1410-1416, issn 0887-6924, 7 p.Article

Characterisation of an Inclusion Complex Between Cladribine and 2-Hydroxypropyl-β-CyclodextrinVAN AXEL CASTELLI, Valeria; TRIVIERI, Giovanni; ZUCCHELLI, Ilaria et al.Journal of pharmaceutical sciences. 2008, Vol 97, Num 9, pp 3897-3906, issn 0022-3549, 10 p.Article

Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases : Natural evolution or latrogenic causation?LING, Silvia; JOSHUA, Douglas E; GIBSON, John et al.American journal of hematology. 2006, Vol 81, Num 2, pp 110-114, issn 0361-8609, 5 p.Article

Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies : fludarabine and cladribineVAN DEN NESTE, Eric; CARDOEN, Sabine; OFFNER, Fritz et al.International journal of oncology. 2005, Vol 27, Num 4, pp 1113-1124, issn 1019-6439, 12 p.Article